{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11345865",
  "DateCompleted": {
    "Year": "2001",
    "Month": "06",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2006",
    "Month": "11",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "fre"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0035-2640",
      "JournalIssue": {
        "Volume": "51",
        "Issue": "6",
        "PubDate": {
          "Year": "2001",
          "Month": "Mar",
          "Day": "31"
        }
      },
      "Title": "La Revue du praticien",
      "ISOAbbreviation": "Rev Prat"
    },
    "ArticleTitle": "[Fever in the neutropenic patient].",
    "Pagination": {
      "StartPage": "633",
      "EndPage": "637",
      "MedlinePgn": "633-7"
    },
    "Abstract": {
      "AbstractText": [
        "The neutropenic patient, whatever the cause of neutropenia (drug related, secondary to marrow involvement by malignant disease or to cytotoxic treatment) is at high risk of bacterial and fungal infection. The first symptom (and often the only one) of infection is fever. The guidelines for management of the febrile neutropenic patient are precise and simple and have been widely accepted for more than 30 years allowing a dramatic decrease of the infectious mortality during episodes of neutropenia."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service d'h\u00e9matologie CHU de Nantes 44035 Nantes. nmilpied@chu-nantes.fr"
          }
        ],
        "LastName": "Milpied",
        "ForeName": "N",
        "Initials": "N"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ],
    "VernacularTitle": "Fi\u00e8vre chez le malade neutrop\u00e9nique."
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Rev Prat",
    "NlmUniqueID": "0404334",
    "ISSNLinking": "0035-2640"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Rev Prat 2001 Nov 1;51(17):1891"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Bacterial Infections"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Mycoses"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ]
}